1. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD;
2. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;
3. Center for International Blood and Marrow Transplant Research, Department of Medicine, and
4. Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI;
5. Department of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
6. Emmes Corporation, Rockville, MD;
7. National Marrow Donor Program, Minneapolis, MN;
8. Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC;
9. Department of Hematology/Hematopoietic Cell Transplantation (HCT), City of Hope National Medical Center, Duarte, CA;
10. Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD;
11. Michigan Medicine Bone Marrow Transplant and Leukemia, C. S. Mott Children’s Hospital, University of Michigan, Ann Arbor, MI;
12. Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS;
13. Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA;
14. Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University Medical Center, Stanford, CA; and
15. Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN